Cardiovascular comorbidity in psoriasis - psoriatic inflammation is more than just skin deep

Katharina S Kommoss1,2, Alexander Enk1, Mathias Heikenwälder2

  • 1Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.

Insights

Psoriasis involves systemic inflammation, increasing cardiovascular risk. Managing comorbidities is crucial for patients, requiring interdisciplinary care to address vascular inflammation and heart disease.

Area of Science:

  • Dermatology
  • Cardiology
  • Immunology

Background:

  • Psoriasis is increasingly understood as a systemic inflammatory condition, not just a skin disease.
  • Guidelines recommend managing comorbidities like metabolic and cardiovascular diseases in psoriasis patients.
  • Psoriasis is now recognized by cardiologists as a risk factor for cardiovascular inflammation.

Purpose of the Study:

  • To review epidemiological, mechanistic, and management aspects of psoriasis and its comorbidities.
  • To contextualize findings for physicians treating psoriasis patients.
  • To highlight interdisciplinary care efforts for vascular inflammation and cardiovascular disease in psoriasis.

Main Methods:

  • Literature review was conducted.
  • Key findings on epidemiology, mechanisms, and management were summarized.

Main Results:

  • Research is ongoing to understand the mechanisms of systemic inflammation in psoriasis.
  • Studies on treating cardiovascular comorbidities with dermatological therapies show mixed results.
  • Diagnosing psoriasis has implications for preventing and treating associated diseases.

Conclusions:

  • Understanding psoriasis comorbidities necessitates interdisciplinary patient care.
  • This article focuses on advancements in managing vascular inflammation and cardiovascular disease in psoriasis patients.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
58
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
36
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
20
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
21